Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Update
Canadian Kidney Cancer Forum · Canadian Urological Association Journal · 2013
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Canadian Urological Association Journal · Canadian Urological Association · article · 2013
Abstract
4 K idney cancer, predominantly renal cell carcinoma (RCC), remains the most lethal genitourinary malignancy and kills more than 1500 Canadians a year. 1 In 2008, the first Canadian Kidney Cancer Forum was held and a clinical management consensus was developed and reported.2 In January 2009, a second forum was convened near Toronto, Ont., with multidisciplinary attendees, this time including researchers and the Board of Kidney Cancer Canada (www.kidneycancercanada.org).During the conference, the 2008 consensus was reviewed and updated using the same process.This report is a brief overview of those updates using the same format and should be read in conjunction with that report.
2 Explanatory text has been omitted in this version if no significant new information has become available.This document represents the current consensus of the attendees who are now the founding members of a new organization, the Kidney Cancer Research Network of Canada.This network will be the subject of future discussion and reports but is intended to begin as an informal, inclusive virtual network of researchers; clinical, translational and basic, with a common interest in kidney cancer research.The forum addressed strategies for kidney cancer control in Canada, which included planning for a Canadian Kidney Cancer Database, collaboration to validate follow-up guidelines defined by the Canadian Urological Association, a coordinated approach to genetic testing for genes relevant to kidney cancer and the initiation of a process to define quality indicators for the management of kidney cancer as part of an overall strategy to define centres of excellence.3 The attendees are developing a position paper on kidney cancer education, research and treatment in Canada that will include the full consensus combining this update with the 2008 statements.Finally, the forum was held with Kidney Cancer Canada whose members continue to monitor access to targeted therapeutic agents across the country.Attendees reaffirmed their support for equal access to these treatments for all Canadians in whom there is a clinical rationale.
Open the resolved locator · 10.5489/cuaj.1069
Metadata licence: OpenAlex metadata (CC0)